Bank of Montreal’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Bank of Montreal’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-69	Closed	–	–	4316
2016 Q3	$0	Sell	69 -4,231	-98%	-$19.3K	﹤0.01%	4319
2016 Q2	$23K	Buy	4,300 +150	+4%	+$855	﹤0.01%	3343
2016 Q1	$20K	Buy	4,150 +150	+4%	+$659	﹤0.01%	3415
2015 Q4	$19K	Sell	4,000 -103	-3%	-$446	﹤0.01%	3428
2015 Q3	$15K	Sell	4,103 -998	-20%	-$6.93K	﹤0.01%	3366
2015 Q2	$43K	Buy	5,101 +332	+7%	+$3.31K	﹤0.01%	3055
2015 Q1	$43K	Buy	+4,769	New	+$59.9K	﹤0.01%	2981

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Bank of Montreal's CPHR Position: Q4 2016 in Review

Bank of Montreal sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 69 shares.

Bank of Montreal first reported a position in CPHR in Q1 2015 and held it in 7 quarters. The position peaked at $43K in Q2 2015. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Bank of Montreal reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Bank of Montreal sold 69 Cipher Pharmaceuticals Inc. shares in Q4 2016.
Bank of Montreal first reported a position in Cipher Pharmaceuticals Inc. in Q1 2015 and held it in 7 quarters.
Bank of Montreal's Cipher Pharmaceuticals Inc. position peaked at $43K in Q2 2015.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Bank of Montreal's 13F filing for Q4 2016, filed 6 Feb 2017.